CellaVision builds digital microscopy systems and software that automate blood cell morphology analysis in clinical hematology labs. Its instruments capture and classify white blood cells, red cells and platelets from blood smears, helping labs standardize reviews and cut manual microscope time. Hospitals and reference laboratories use the platform as a core tool for routine differential counts and digital collaboration across sites.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 194.8 | — | 41.5 | 38.1% |
| Q2 2025 | 191.3 | — | 37.6 | -2.7% |
| Q3 2025 | 175.6 | — | 31.3 | 1.1% |
| Q4 2025 | 197.2 | — | 42.6 | 3.9% |
| Q1 2026 | 166.4 | -14.6% | 22.5 | -45.8% |
| Q2 2026 | 199.9 | 4.5% | 32.6 | -13.2% |
All markets — KeepWinning global stock screener
Other companies on Stockholm: Duni AB (publ) (DUNI), Nordrest Holding AB (publ) (NREST), Rejlers AB (publ) (REJL B), BHG Group AB (publ) (BHG), Egetis Therapeutics AB (publ) (EGTX), Idun Industrier AB (publ) (IDUN B)